HMGB1 and systemic lupus erythematosus: Our results showed there were more SA-β-gal-positive cells in BM-MSCs when treated with bone marrow supernatant from SLE patients, interestingly, which could be reversed by a neutralizing anti-HMGB1 monoclonal antibody (Figure 2A, 2B).